Erythropoiesis‐Stimulating Agent Therapy in Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis 2026

View at publisher

Authors: Masayuki Tanemoto

DOI: 10.1002/1744-9987.70124

Cited by: 0

References: 4

Abstract

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

Erythropoietin and Anemia Treatment Dialysis and Renal Disease Management Biosimilars and Bioanalytical Methods

References 4